Bioequivalence Study of Nalfurafine Hydrochloride Orally Disintegrating Tablets on Fasting and Fed in Humans

NCT07478133 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Pruritus

Interventions

DRUG: Nalfurafine Hydrochloride Orally Disintegrating Tablets
DRUG: Remitch®

Sponsor

Shandong New Time Pharmaceutical Co., LTD